Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Donofrio

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 20, 2013
A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpointC William Hanke, Rhoda S Narins, Fredric Brandt, et al.
JAMA Dermatology|June 17, 2026
Development of a Core Outcome Domain Set for Facial AgingMcKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 20, 2013
A randomized, placebo-controlled, double-blind phase III trial investigating the efficacy and safety of incobotulinumtoxinA in the treatment of glabellar frown lines using a stringent composite endpointC William Hanke, Rhoda S Narins, Fredric Brandt, et al.
JAMA Dermatology|June 17, 2026
Development of a Core Outcome Domain Set for Facial AgingMcKenzie A Dirr, Areeba Ahmed, Daniel I Schlessinger, et al.
Pageof 2